by admin | Nov 11, 2019 | Funding
A company developing a means to edit RNA has raised more than $30 million in a venture capital funding round. Seattle-based Shape Therapeutics, or ShapeTx, said that it had raised a $35.5 million Series A financing, led by New Enterprise Associates and with...
by admin | Nov 11, 2019 | Funding
Two of the largest drugmakers in the country are investing in a startup applying artificial intelligence in pathology. Boston-based PathAI said that it had closed its $75 million Series B financing round with funding from New York-based Bristol-Myers Squibb and the...
by admin | Nov 4, 2019 | Funding
The startup describes its software as providing clinical labs with more streamlined and accurate analysis, interpretation and reporting for accelerating personalized medicine programs. A startup that aims to provide a software-as-a-service platform to allow genomic...
by admin | Nov 4, 2019 | Funding, Licensing
Biopharmaceutical company Alvotech announced that Abu Dhabi-based investment company, Yas Holding, has acquired a 2.5% stake in their business and signed an agreement for the exclusive partnership and supply of three Alvotech biosimilar candidates, which Yas Holding...
by admin | Oct 28, 2019 | Funding
Connecticut-based microbiome therapy company Azitra recently announced a $14 million haul in Series A funding. The round was led by KdT Ventures and previous investor Bios Partners, along with Godfrey Capital and Connecticut Innovations. Azitra, which focuses on...
by admin | Oct 28, 2019 | Funding
Pepticom’s unique artificial intelligence (AI) technology streamlines and significantly accelerates the ability of researchers to discover advanced peptide-based drug candidates. Peptides are used in various therapies, and are recognized for being highly...